Navigation Links
Aprea to Present Phase I/II Trial Design
Date:5/18/2010

y. The other main owners are Industrifonden, Ostersjostiftelsen and Praktikerinvest.

About APR-246

APR-246 has been developed based upon results from researcher at the Karolinska Institute. The researchers have discovered that the substance is more efficacious in cancer cells than normal cells, which indicates it could produce significantly fewer side effects than conventional cancer treatments. By inducing the protein p53 the compound makes sure that the cellular suicide program is activated to eliminate the cancer cells. This has been shown in laboratories and animal studies with good results. A unique characteristic of the substance is that it can activate p53 even when the gene is inactivated due to a mutation. Cancers with mutated p53 are often resistant to conventional treatment.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation Pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's projects 12 compounds are undergoing clinical trials. The portfolio contains a total of 21 potential first-in-class products. http://www.karolinskadevelopment.com

For more formation, please contact:

Thomas Uhlin, CEO Aprea AB, +46-705-335
'/>"/>

SOURCE Karolinska Development and Aprea
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Avicena Group to Present at Noble Financial Conference
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
8. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 Pipette.com announces their ... Twitter followers can submit their #HolidayInTheLab pictures for a ... lab mates. , For those struggling to think of ... Pipette.com Holiday in the Lab Contest provides the ideal ... followers to send pictures of their chemistree, holiday ...
(Date:12/24/2014)... ST. LOUIS , Dec. 23, 2014 /PRNewswire/ ... announced today that the waiting period under the ... with the acquisition expired on December 22, 2014, ... and review requirement for the acquisition of the ... U.S. antitrust clearance satisfies another condition to ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... NEW YORK, July 7 Reportlinker.com just added ... , , World Endoscopy Systems ... http://www.reportlinker.com/p0109885/World-Endoscopy-Systems-Market.html?utm_source=PRNWire&utm_medium=PR&utm_campaign=PRNWire , ... for Endoscopy Systems in US$ Million. The major ...
... Medical Inc., a leader in fluorescence in vivo imaging ... new Cat-K FAST (TM) imaging ... progression and therapeutic response in vivo . Cathepsin K ... in a range of bone-related diseases, including cancer metastasis to bone, ...
... a leader in forest tree improvement technologies, ... that are utilizing technology in-licensed from Senesco Technologies, Inc. ... companies had previously announced that trees that incorporate Senesco ... field trials. , , Selected trees from ...
Cached Biology Technology:New Report Just Published: World Endoscopy Systems Market Report 2New Report Just Published: World Endoscopy Systems Market Report 3New Report Just Published: World Endoscopy Systems Market Report 4New Report Just Published: World Endoscopy Systems Market Report 5New Report Just Published: World Endoscopy Systems Market Report 6New Report Just Published: World Endoscopy Systems Market Report 7New Report Just Published: World Endoscopy Systems Market Report 8New Report Just Published: World Endoscopy Systems Market Report 9New Report Just Published: World Endoscopy Systems Market Report 10New Report Just Published: World Endoscopy Systems Market Report 11New Report Just Published: World Endoscopy Systems Market Report 12New Report Just Published: World Endoscopy Systems Market Report 13New Report Just Published: World Endoscopy Systems Market Report 14New Report Just Published: World Endoscopy Systems Market Report 15New Report Just Published: World Endoscopy Systems Market Report 16New Report Just Published: World Endoscopy Systems Market Report 17New Report Just Published: World Endoscopy Systems Market Report 18New Report Just Published: World Endoscopy Systems Market Report 19New Report Just Published: World Endoscopy Systems Market Report 20New Report Just Published: World Endoscopy Systems Market Report 21VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent 2ArborGen and Senesco Announce Wood Quality Results 2ArborGen and Senesco Announce Wood Quality Results 3ArborGen and Senesco Announce Wood Quality Results 4
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... , Dec. 4, 2014 Increased ... boosted investments in new testing and inspection technologies. ... given rise to a range of innovative test ... requirements of Generation Y, which is generally more ... a result, product development strategies of test equipment ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... CryoSat was launched in 2010 to measure sea-ice thickness in ... been exploited for other studies. High-resolution mapping of the topography ... ice mission,s repertoire. The main objective of the polar-orbiting ... and monitor changes in the ice sheets that blanket Greenland ...
... borders with colourful bedding plants, scientists at the Universities of ... attractive to bees rather than humans. Published today in the ... reveals that Velcro-like cells on plant petals play a crucial ... wind gets up., The study focuses on special cells found ...
... led by researchers from McGill University provides new insights into ... finding that promises to contribute to the study of heart ... The research, published in the Proceedings of the National ... in the heart wall are locally arranged in a special ...
Cached Biology News:CryoSat goes to sea 2Blowing in the wind: How hidden flower features are crucial for bees 2Study provides new insights into structure of heart muscle fibers 2